The different genes expression in clinical para-tumor and pancreatic ductal adenocarcinoma samples

Pancreatic cancer is a highly malignant tumor. Current treatments are not effective. Hence, more effective treatment methods need to be sought. We aim to identify genes that differ between clinical para-tumor and pancreatic ductal adenocarcinoma samples by RNA-seq, and subsequently explore their functions, in the hope of finding better targets for pancreatic cancer treatment. Overall design: RNA-seq for clinical para-tumor and pancreatic ductal adenocarcinoma samples